NDC product
Robitussin Direct Runny Nose
NDC 0031-9304 · Haleon US Holdings LLC
Key facts
| Product NDC | 0031-9304 |
|---|---|
| Proprietary name | Robitussin Direct Runny Nose |
| Labeler | Haleon US Holdings LLC |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Marketing start | Jul 15, 2022 |
| Marketing end | May 15, 2024 |
| Listing certified through | May 15, 2024 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: